China Exoskeleton Market Analysis by Type (Powered Exoskeleton, Passive Exoskeleton), Body Part, Sales Channel and End Use: Consumption (Units), Pricing Analysis, Trends and Forecast Till 2033

Market Overview

China Exoskeleton Market recorded a sale of 20,370 units in 2024 and is estimated to reach a volume of 105,676 units by 2033 with a CAGR of 21.6% during the forecast period.

The increasing prevalence of stroke, spinal cord injuries, and neurological disorders is significantly driving the demand for advanced rehabilitation technologies in healthcare facilities across China. Stroke has emerged as one of the country’s most pressing health challenges, currently ranking as the leading cause of death and disability. National health reports indicate that by 2020, approximately 17.8 million adults in China had experienced a stroke, with around 3.4 million new cases reported each year. This alarming trend underscores the need for long-term rehabilitation therapy to help millions of patients regain mobility and motor function. Additionally, global health studies have projected that China saw about 4.1 million new stroke cases in 2021, further emphasizing the rapidly expanding population in need of rehabilitation assistance.

Alongside the rise in stroke cases, spinal cord injuries are also increasing, primarily due to road accidents, falls, and workplace incidents. Epidemiological research estimates that over 759,000 individuals in China are currently living with traumatic spinal cord injuries, with approximately 66,000 new cases emerging annually. This situation creates a notable demand for long-term rehabilitation solutions. Many of these conditions lead to partial or complete mobility loss, necessitating intensive physiotherapy and gait training over extended periods.

Given that traditional rehabilitation methods often depend heavily on manual therapy and limited clinical resources, hospitals and rehabilitation centers are increasingly turning to robotic exoskeleton technologies. These innovations enhance treatment efficiency and improve patient outcomes by enabling assisted walking and repetitive motion therapy, which help rebuild muscle strength, restore neural connections, and accelerate recovery. The incorporation of sensors, AI-driven motion control, and real-time gait monitoring further enhances the precision of rehabilitation efforts.

Therefore, the growing challenges posed by neurological disorders and mobility impairments are emerging as significant growth factors for the China Exoskeleton market, particularly within the healthcare and rehabilitation sectors. Demand for advanced robotic therapy solutions continues to rise in response to these pressing needs.

Pricing Analysis

The pricing trend for exoskeleton devices in China is projected to show a gradual upward trajectory from 2024 to 2033, driven by technological advancements and increasing demand in healthcare, industrial, and consumer mobility sectors. In 2024, the average unit price is expected to be around USD 1,200. This marks the beginning of broader commercialization, as manufacturers focus on market penetration and raising product awareness. By 2025 and 2026, prices are set to rise to approximately USD 1,500 and USD 1,800 per unit, respectively. This increase reflects a growing acceptance of exoskeletons in rehabilitation centers and industrial workplaces, where the benefits of wearable robotic assistance are becoming more recognized. 

During this period, manufacturers are enhancing their devices by integrating improved motion sensors, utilizing lightweight materials, and optimizing battery efficiency. While these advancements contribute to slightly higher production costs, they significantly boost device performance. Between 2027 and 2028, prices are expected to continue to rise moderately, reaching nearly USD 1,900 and USD 2,100 per unit. This increase is fueled by heightened research investments and the introduction of more sophisticated control systems and AI-assisted movement capabilities, allowing for more natural gait support and ergonomic advantages for both workers and patients.

From 2029 to 2033, the pricing trend is anticipated to stabilize with incremental increases from USD 2,140 to USD 2,300. This stabilization suggests that the market is entering a maturity phase, where economies of scale in manufacturing and intensified competition among domestic robotics firms help keep price increases in check, despite ongoing technological advancements. 

Overall, this steady price progression reflects a balance between innovation and affordability. As manufacturers continue to introduce advanced features that enhance device functionality, they are also committed to maintaining cost competitiveness in domestic and international markets. With production volumes increasing and component costs gradually decreasing, exoskeleton systems are expected to become more accessible to hospitals, rehabilitation clinics, and industrial operators. This evolving pricing structure illustrates the broader development of the exoskeleton market in China, where continuous technological improvements and growing adoption across various sectors are shaping future market dynamics.

Segmental Analysis- End Use

The end-use distribution of the China exoskeleton market showcases the varied applications of wearable robotic technology across healthcare, defense, industrial, and consumer sectors. Among these, healthcare and rehabilitation dominate the market, accounting for nearly 40% of total demand. This leadership stems from the increasing number of patients experiencing strokes, spinal cord injuries, and neurological disorders who require long-term mobility support and rehabilitation therapy. Hospitals and rehabilitation centers are adopting robotic exoskeleton systems to enhance patient recovery outcomes, facilitate assisted walking, and alleviate the physical demands placed on physiotherapists. Continuous investment in advanced medical technologies and the growth of rehabilitation facilities in major Chinese cities are further propelling the adoption of these systems.

The industrial segment represents another substantial portion of the market, fueled by China's robust manufacturing base and the growth of logistics and construction sectors. Industrial exoskeletons are engineered to reduce worker fatigue, enhance lifting capabilities, and decrease the risk of workplace injuries, especially in physically demanding environments like warehouses, factories, and heavy construction sites. As companies prioritize improving worker safety and productivity, wearable assistive technologies are becoming increasingly integrated into workplace ergonomics strategies.

The military and defense sector also plays a significant role in the market. Defense organizations are examining exoskeleton technologies to improve soldier endurance, mobility, and load-carrying abilities during lengthy missions or operations in challenging terrain. Ongoing research and prototype development by defense contractors and research institutions are fostering the incorporation of wearable robotics into military applications.

Meanwhile, the consumer and personal mobility segment currently holds the smallest market share but is showing promise for future growth. Lightweight exoskeletons aimed at providing everyday mobility assistance, supporting outdoor activities, and aiding the elderly are entering the market as companies develop more compact and affordable designs. With technological advancements and a gradual decrease in product costs, the adoption of these systems in personal mobility applications is anticipated to rise, contributing to the long-term expansion of the China exoskeleton market.

Company Analysis

The China exoskeleton market features key players such as Fourier Intelligence, Shenzhen Zuowei Technology Co., Ltd., ULS Robotics, Siasun Robot & Automation Co., Ltd., Agibot, Unitree, along with several other prominent companies.